Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 47801-47850 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05472857
Clinical Study of CLDN18.2-targeting CAR T Cells in Advanced Solid Tumors With Positive CLDN18.2 Expression
PHASE1Recruiting
30 participants
Started: Aug 8, 2022 · Completed: Dec 31, 2024
4 conditions2 sponsors1 location
NCT05728359
Genomic Determinants of Outcome in Cardiogenic Shock
N/ARecruiting
300 participants
Started: Aug 8, 2022 · Completed: Nov 1, 2025
1 condition2 sponsors1 location
NCT04989790
"Clinical Effectiveness of the PICU Up! Multifaceted Early Mobility Intervention for Critically Ill Children"
NARecruiting
1,440 participants
Started: Aug 8, 2022 · Completed: Mar 31, 2026
4 conditions2 sponsors11 locations
NCT06065813
Neoadjuvant Triprizumab and Radiotherapy in Operable Patients With Stage IIA-IIIA Non-small Cell Lung Cancer
PHASE2Recruiting
20 participants
Started: Aug 8, 2022 · Completed: May 30, 2026
4 conditions2 sponsors1 location
NCT05254171
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
PHASE2/PHASE3Recruiting
600 participants
Started: Aug 8, 2022 · Completed: Jan 1, 2027
3 conditions1 sponsor93 locations
NCT05413655
A Study of Oral EX039 in Subjects with Mild Alzheimer's Disease
PHASE2Recruiting
120 participants
Started: Aug 8, 2022 · Completed: Feb 28, 2027
1 condition2 sponsors1 location
NCT04558541
A Developmental Framework For Linking Phonological And Morpho-syntactic Sequential Pattern Rules In DLD: Production
NARecruiting
400 participants
Started: Aug 7, 2022 · Completed: Jul 31, 2026
3 conditions2 sponsors2 locations
NCT05466786
Distribution of the Homologous Recombination-related (HRR) Genesmutationsand HRD in Breast Cancer
N/ARecruiting
255 participants
Started: Aug 7, 2022 · Completed: May 31, 2027
2 conditions1 sponsor1 location
NCT05406349
Neural Mechanisms of Spatial Representations Beyond the Self
NARecruiting
60 participants
Started: Aug 6, 2022 · Completed: Apr 30, 2027
1 condition4 sponsors1 location
NCT05445310
Adjuvant Furmonertinib in Stage IA With High Risk Factors and Stage IB Non-small Cell Lung Cancer
PHASE2Recruiting
114 participants
Started: Aug 6, 2022 · Completed: Jul 1, 2026
1 condition1 sponsor1 location
NCT05434130
Modulating Exercise Dosage to Improve Concussion Recovery
PHASE2Recruiting
216 participants
Started: Aug 5, 2022 · Completed: Feb 1, 2027
5 conditions4 sponsors3 locations
NCT05532930
An Exploratory Study of Using Magnetic Resonance Prognostic Imaging Markers for Radiotherapy In Patients With Cervix Cancer (EMPIRIC Study)
N/ARecruiting
40 participants
Started: Aug 5, 2022 · Completed: Mar 1, 2026
1 condition3 sponsors1 location
NCT05063201
Cariprazine for Comorbid Cocaine and Opioid Use Disorder
PHASE2Recruiting
48 participants
Started: Aug 5, 2022 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT05376267
Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)
NARecruiting
900 participants
Started: Aug 5, 2022 · Completed: Mar 31, 2028
3 conditions3 sponsors54 locations
NCT04833816
Ketamine Low dOse Evaluation on Morphine Consumption in Traumatic Patient
PHASE3Recruiting
140 participants
Started: Aug 5, 2022 · Completed: Jan 3, 2026
1 condition1 sponsor1 location
NCT05328505
Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas in Salvage Radiotherapy for Prostate Cancer
NARecruiting
80 participants
Started: Aug 5, 2022 · Completed: Aug 31, 2030
1 condition1 sponsor1 location
NCT04817462
Liver Biopsy In Haemophilia Gene Therapy
NARecruiting
10 participants
Started: Aug 5, 2022 · Completed: Jul 1, 2025
2 conditions1 sponsor1 location
NCT05982691
Development of Asian Consortium for Data Collection and Clinical Trial of CNS Tumors
N/ARecruiting
400 participants
Started: Aug 5, 2022 · Completed: Dec 31, 2032
3 conditions1 sponsor1 location
NCT05306496
Laparoscopic Inguinal and Femoral heRniA rePaIr Using Pre-shapeD 4DMESH® (4DLap)
NARecruiting
200 participants
Started: Aug 4, 2022 · Completed: Sep 30, 2029
2 conditions1 sponsor9 locations
NCT05426083
Left Ventricular Physiological Effects of Veno-Arterial Extracorporeal Membrane Oxygenation Support During Cardiogenic Shock
N/ARecruiting
200 participants
Started: Aug 4, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05563623
The Beijing Angle Closure Progression Study
N/ARecruiting
825 participants
Started: Aug 4, 2022 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT06809699
Human Leukocyte Antigen (HLA) Mismatched Related Allogeneic Hematopoietic Stem Cell Transplantation
PHASE1Recruiting
29 participants
Started: Aug 4, 2022 · Completed: Oct 31, 2027
1 condition1 sponsor1 location
NCT05304585
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
PHASE3Recruiting
205 participants
Started: Aug 4, 2022 · Completed: Jun 30, 2030
3 conditions2 sponsors177 locations
NCT06809712
Human Leukocyte Antigen (HLA) Mismatched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation
PHASE1Recruiting
29 participants
Started: Aug 4, 2022 · Completed: Oct 31, 2027
1 condition1 sponsor1 location
NCT05453721
Effect and Long-Term Outcomes of Indocyanine Green Fluorescence Imaging Method Versus Modified Inflation-Deflation Method in Identification of Intersegmental Plane(IMPLANE-0529)
NARecruiting
272 participants
Started: Aug 4, 2022 · Completed: Dec 31, 2027
2 conditions10 sponsors1 location
NCT05184933
Sleep and Circadian Mechanisms in Hypertension
NARecruiting
32 participants
Started: Aug 4, 2022 · Completed: Mar 30, 2028
5 conditions1 sponsor1 location
NCT05520359
Spinal Stimulation and Mobility Devices
NARecruiting
20 participants
Started: Aug 4, 2022 · Completed: Dec 31, 2026
5 conditions2 sponsors1 location
NCT05491512
A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer
PHASE2Recruiting
121 participants
Started: Aug 4, 2022 · Completed: Aug 4, 2026
5 conditions1 sponsor7 locations
NCT05225428
Video Education With Result Dependent dIsclosure
NARecruiting
1,020 participants
Started: Aug 4, 2022 · Completed: Sep 1, 2026
9 conditions3 sponsors1 location
NCT05464030
Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)
PHASE1Recruiting
200 participants
Started: Aug 4, 2022 · Completed: Aug 7, 2026
1 condition2 sponsors35 locations
NCT05670262
The Roles of Human Microbiome and Vitamin D in the Development of Childhood Allergic Diseases
N/ARecruiting
6,000 participants
Started: Aug 4, 2022 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT05638490
Study on Prenatal Diagnosis and Closed-loop Management System of Congenital Talipes Equinovarus
N/ARecruiting
100 participants
Started: Aug 3, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05489237
First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors
PHASE1Recruiting
269 participants
Started: Aug 3, 2022 · Completed: Nov 3, 2027
5 conditions1 sponsor18 locations
NCT04676048
ASC618 Gene Therapy in Hemophilia A Patients
PHASE1/PHASE2Recruiting
12 participants
Started: Aug 3, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06413004
Brachyspira and Intestinal Allergy-like Immune Reactions in Patients With Irritable Bowel Syndrome (IBS)
NARecruiting
200 participants
Started: Aug 3, 2022 · Completed: Jan 1, 2027
2 conditions1 sponsor1 location
NCT05468970
Study on Clinical Features, Treatment Mode and Survival of Bone and Soft Tissue Tumors
N/ARecruiting
6,000 participants
Started: Aug 3, 2022 · Completed: Jul 31, 2032
2 conditions1 sponsor1 location
NCT04531995
One Million Cancer Treatment Months
N/ARecruiting
166,000 participants
Started: Aug 3, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor4 locations
NCT05463263
A Phase 1/2 Study of STP938 for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas
PHASE1/PHASE2Recruiting
180 participants
Started: Aug 3, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor15 locations
NCT05261399
Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment
PHASE3Recruiting
324 participants
Started: Aug 3, 2022 · Completed: Dec 17, 2026
2 conditions1 sponsor283 locations
NCT06054321
Psychopharmacotherapy for Depressive Patients
NARecruiting
400 participants
Started: Aug 3, 2022 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT05351333
Conditioning & Open-Label Placebo (COLP) for Opioid Management in Intensive Inpatient Rehabilitation
NARecruiting
66 participants
Started: Aug 3, 2022 · Completed: Jul 31, 2026
3 conditions2 sponsors1 location
NCT04847453
Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis
PHASE1Recruiting
24 participants
Started: Aug 3, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor16 locations
NCT05719259
Perpetual Observational Study - Ventilator Associated Pneumonia
N/ARecruiting
20,000 participants
Started: Aug 3, 2022 · Completed: Mar 1, 2026
1 condition4 sponsors35 locations
NCT05348876
A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)
PHASE4Recruiting
50 participants
Started: Aug 3, 2022 · Completed: Jan 28, 2026
1 condition1 sponsor25 locations
NCT06523582
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
N/ARecruiting
750 participants
Started: Aug 3, 2022 · Completed: Mar 1, 2037
26 conditions3 sponsors3 locations
NCT06732531
Safety, Tolerability, and Preliminary Efficacy of BH011 in Subjects With Non-Muscle-Invasive Bladder Cancer
PHASE1/PHASE2Recruiting
48 participants
Started: Aug 3, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor6 locations
NCT05434026
Chinese Colorectal Cancer Database
N/ARecruiting
200,000 participants
Started: Aug 3, 2022 · Completed: Jun 22, 2032
3 conditions8 sponsors1 location
NCT05178862
A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole
PHASE3Recruiting
220 participants
Started: Aug 3, 2022 · Completed: Feb 28, 2027
2 conditions1 sponsor75 locations
NCT06498323
Intravenous TNK vs TPA for AIS Treatment on MSU,a Prospective Multicenter RCT
PHASE4Recruiting
160 participants
Started: Aug 3, 2022 · Completed: Aug 31, 2025
3 conditions1 sponsor1 location
NCT05446272
The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial
NARecruiting
478 participants
Started: Aug 3, 2022 · Completed: Mar 31, 2027
3 conditions2 sponsors20 locations